| Woodridge Behavioral Center | |
| 600 North 7th Street, West Memphis, Arkansas 72301 | |
| (870) 394-4113 | |
| Not Available |
| Name | Woodridge Behavioral Center |
|---|---|
| Type | Psychiatric Hospital |
| Location | 600 North 7th Street, West Memphis, Arkansas |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 044021 |
| NPI Number | 1134521685 |
| Organization Name | WOODRIDGE OF WEST MEMPHIS, LLC |
| Doing Business As | PERIMETER BEHAVIORAL HOSPITAL OF WEST MEMPHIS |
| Address | 600 N 7th St, West Memphis, AR 72301 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 870-394-7100 |
News Archive
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
Between 1998 and 2008, heart-failure related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study in the October 19 issue of JAMA. Also, 1-year mortality rates declined slightly during this period, but remain high.
Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
› Verified 2 days ago
News Archive
ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.
Between 1998 and 2008, heart-failure related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study in the October 19 issue of JAMA. Also, 1-year mortality rates declined slightly during this period, but remain high.
Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases.
› Verified 2 days ago
Baptist Memorial Hospital-crittenden, Inc Acute Care Hospital Location: 2100 North Seventh Street, West Memphis, Arkansas 72301 Phone: (870) 394-7800 | |
Woodridge Behavioral Center Psychiatric Hospital Location: 600 North 7th Street, West Memphis, Arkansas 72301 Phone: (870) 394-4113 |